IRIS
Cattaneo, Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.543
AS - Asia 3.415
SA - Sud America 2.084
EU - Europa 493
Continente sconosciuto - Info sul continente non disponibili 307
AF - Africa 116
OC - Oceania 2
Totale 9.960
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.359
BR - Brasile 1.638
SG - Singapore 1.542
VN - Vietnam 1.165
CN - Cina 289
IT - Italia 284
AR - Argentina 199
ID - Indonesia 94
EC - Ecuador 86
BD - Bangladesh 75
CA - Canada 61
MX - Messico 61
HK - Hong Kong 59
CO - Colombia 46
ZA - Sudafrica 46
RU - Federazione Russa 41
PY - Paraguay 39
IQ - Iraq 38
IN - India 33
CL - Cile 28
GB - Regno Unito 25
UA - Ucraina 23
JM - Giamaica 20
DE - Germania 19
VE - Venezuela 19
FR - Francia 15
PE - Perù 15
PK - Pakistan 15
MA - Marocco 14
EG - Egitto 12
UZ - Uzbekistan 12
DZ - Algeria 10
PL - Polonia 10
KE - Kenya 9
SA - Arabia Saudita 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
ES - Italia 8
JP - Giappone 8
PH - Filippine 8
TR - Turchia 8
AL - Albania 7
IE - Irlanda 7
MY - Malesia 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
HN - Honduras 6
NP - Nepal 6
SN - Senegal 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
FI - Finlandia 5
GT - Guatemala 5
KZ - Kazakistan 5
SE - Svezia 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
IL - Israele 4
JO - Giordania 4
LB - Libano 4
AT - Austria 3
BG - Bulgaria 3
KW - Kuwait 3
NL - Olanda 3
OM - Oman 3
PA - Panama 3
SV - El Salvador 3
AU - Australia 2
BE - Belgio 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
GY - Guiana 1
Totale 9.641
Salva come PNG Salva come JPEG
Città #
San Jose 448
Ho Chi Minh City 434
Ashburn 366
Council Bluffs 320
Singapore 306
Hanoi 238
Dallas 192
São Paulo 124
Beijing 107
Milan 85
Santa Clara 74
Rio de Janeiro 57
Hong Kong 55
Los Angeles 55
Da Nang 51
Rome 44
Haiphong 39
Biên Hòa 37
Phoenix 36
Curitiba 33
Hải Dương 33
Princeton 32
Brasília 31
Assago 30
New York 30
Guayaquil 29
Porto Alegre 26
Thái Bình 26
Abbeville 24
Belo Horizonte 23
Quito 22
Chicago 21
Ninh Bình 21
Salvador 21
Atlanta 20
Brooklyn 20
Campinas 20
Houston 20
Johannesburg 20
Guarulhos 19
Philadelphia 19
Ribeirão Preto 19
Buenos Aires 17
Can Tho 17
Fortaleza 17
Mexico City 17
Santo André 15
Sorocaba 15
Buffalo 14
Jakarta 14
Manaus 14
Miami 14
Montreal 14
Thái Nguyên 14
Wilmington 14
Austin 13
Bogotá 13
Newark 13
Richmond 13
Bắc Giang 12
Kingston 12
Phủ Lý 12
Resistencia 12
Baghdad 11
Cape Town 11
Denver 11
Goiânia 11
Queens 11
Santiago 11
São Gonçalo 11
Turin 11
Viamão 11
Asunción 10
Belém 10
Caxias do Sul 10
Ha Long 10
Lấp Vò 10
Naples 10
Orem 10
Quincy 10
Tashkent 10
The Bronx 10
Warsaw 10
Cao Lanh 9
Cotia 9
Dhaka 9
Las Vegas 9
Medellín 9
Piracicaba 9
Shanghai 9
Boston 8
Cairo 8
Caracas 8
Charlotte 8
Clear Fork 8
Cleveland 8
Columbus 8
Figino 8
Florence 8
Franca 8
Totale 4.275
Salva come PNG Salva come JPEG
Nome #
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. 88
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial 76
"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study 64
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 60
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 59
Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma 54
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 54
A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries 53
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication 51
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis 51
Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review 51
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 51
Aldosterone and progression of kidney disease 50
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk Effects of Acetyl-L-Carnitine Therapy 50
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine 50
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 49
Are non-serious adverse reactions to psychiatric drugs really non-serious ? 46
Antibiotic Therapy Strategies for Treating Gram- Negative Severe Infections in the Critically Ill: A Narrative Review. 45
Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution? 44
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients 44
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation 44
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 44
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients 43
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients 43
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir 43
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 42
Pharmacogenomics of immunosuppressive agents: perspective for individualized therapy 42
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 41
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 41
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 41
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action 41
Drug-induced liver steatosis in patients with HIV infection 40
Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection 40
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney 40
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 40
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out 39
Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs 39
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring 39
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 39
Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events 39
Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients 39
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 39
How to fully protect the kidney in a severe model of progressive nephropathy: A multidrug approach 39
Cyclosporine formulation and Kaposi's sarcoma after renal transplantation 39
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges 39
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action? 38
Effect of combining ACE inhibitor and statin in severe experimental nephropathy 38
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report 38
Psychoactive drugs and HIV: are we sure to treat our patients adequately? 38
Serotonin reuptake inhibitors in pregnancy : can genes help us in predicting neonatal adverse outcome? 38
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma 38
Pharmacovigilance knowledge in family paediatricians. A survey study in Italy 38
Practices of therapeutic drug monitoring in tuberculosis: an international survey. 38
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic 38
Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV 38
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience 38
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 37
Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once 37
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation 37
Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection 37
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury 37
Delayed graft function in kidney transplantation 37
Two-hour blood cyclosporine level does not necessarily predict drug exposure and graft function outcome in stable kidney transplant recipients 37
Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing 37
Perceptions and patterns of use of generic drugs among Italian family pediatricians : first round results of a web survey 37
Comparison of different cyclosporine immunoassays to monitor C-0 and C-2 blood levels from kidney transplant recipients: Not simply overestimation 37
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 37
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: Insights from the MYSS Trial 37
Optimizing immunosuppressive drug dosing in pediatric renal transplantation 37
Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review 36
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients 36
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 36
Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics 36
Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review. 36
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma 36
No effects of nirmatrelvir/ritonavir on darunavir plasma trough concentrations: a case report 36
Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges 36
[Functional loss of the transplanted kidney: immunological and non-immunological factors]. FT La perdita di funzione del rene trapiantato: fattori immunologici e non-immunologici 36
Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients 36
Safety and efficacy of non-standard posology of paracetamol to manage pain in pediatric patients 36
Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics? 36
Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients 36
Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots 35
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 35
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report 35
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics? 35
Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor-Free Regimen 35
When the absence of an interaction can become clinically relevant 35
Multidrug-resistant HIV viral rebound during early syphilis: a case report 35
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 35
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies 35
Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation 35
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations : Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 35
Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper 35
Non-operative management of uncomplicated appendicitis in children, why not? A meta-analysis of randomized controlled trials 35
Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study 35
Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes A prospective randomized double-blind clinical trial 35
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 35
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 34
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies : evidence from a safety study with pilot efficacy measures in adult dystrophic patients 34
Totale 4.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 2 0 0 1 1 1 1 3 4
2022/202319 5 0 3 3 1 1 0 1 1 2 2 0
2023/202414 2 2 3 0 0 0 3 1 0 0 1 2
2024/202517 1 0 0 0 0 3 0 1 2 7 0 3
2025/20267.316 311 480 1.055 2.351 529 180 791 515 387 321 185 211
2026/20272.556 605 407 1.332 212 0 0 0 0 0 0 0 0
Totale 9.960